United States Biotechnology & Medical Research

Amylyx Pharmaceuticals, Inc. (AMLX)

Amylyx Pharmaceuticals experienced significant insider trading activity over the past ninety days, totaling seventeen transactions. Executives offloaded approximately 9.5 million dollars in shares, with no recorded purchases. These divestments occurred amid a 30.1% stock price increase, following the most recent earnings report, reflecting notable selling pressure from leadership.
Ticker: AMLX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Amylyx Pharmaceuticals, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
JUSTIN KLEE Director; Officer Executive Director
Transaction date
Proposed sale
Price
478.95
Quantity 44,898
Value US$3,053,805
4.0
JAMES M FRATES Officer Officer
Transaction date
Proposed sale
Price
69.18
Quantity 45,328
Value US$1,056,817
2.9
JOSHUA BARRY COHEN Director; Officer Executive Director
Transaction date
Proposed sale
Price
128.50
Quantity 33,673
Value US$4,467,534
3.3
MILNE GEORGE M JR Non-Executive Director
Transaction date
Planned sale
Price
27.70
Quantity 30,000 -3.7%
Value US$830,904
3.3
GEORGE MILNE Director Non-Executive Director
Transaction date
Proposed sale
Price
27.79
Quantity 100,000
Value US$2,779,000
3.5
Mazzariello Gina Chief Legal Officer Officer
Transaction date
Sale
Price
33.34
Quantity 11 -0.0%
Value US$367
3.5
Mazzariello Gina Chief Legal Officer Officer
Transaction date
Sale
Price
32.46
Quantity 9,525 -4.8%
Value US$309,140
2.9
Cohen Joshua B Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
33.15
Quantity 919 -0.0%
Value US$30,464
2.9
Cohen Joshua B Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
32.16
Quantity 29,545 -0.8%
Value US$950,040
2.9
Klee Justin B. Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
33.16
Quantity 1,439 -0.0%
Value US$47,710
2.9
Klee Justin B. Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
32.13
Quantity 29,025 -0.8%
Value US$932,553
3.7
Bedrosian Camille L Chief Medical Officer Officer
Transaction date
Sale
Price
33.09
Quantity 2,081 -0.7%
Value US$68,864
3.7
Bedrosian Camille L Chief Medical Officer Officer
Transaction date
Sale
Price
32.21
Quantity 7,947 -2.8%
Value US$256,004
4.0
FRATES JAMES M Chief Financial Officer Officer
Transaction date
Sale
Price
33.23
Quantity 1,042 -0.4%
Value US$34,626
4.0
FRATES JAMES M Chief Financial Officer Officer
Transaction date
Sale
Price
32.27
Quantity 9,768 -4.0%
Value US$315,195
3.5
Mazzariello Gina Officer Officer
Transaction date
Proposed sale
Price
32.46
Quantity 9,536
Value US$309,506
4.0
Frates James M Officer Officer
Transaction date
Proposed sale
Price
32.36
Quantity 10,810
Value US$349,821
2.9
Cohen Joshua B Officer; Director Executive Director
Transaction date
Proposed sale
Price
32.19
Quantity 30,464
Value US$980,504
3.7
Bedrosian Camille L Officer Officer
Transaction date
Proposed sale
Price
32.40
Quantity 10,028
Value US$324,868
2.9
Klee Justin B. Officer; Director Executive Director
Transaction date
Proposed sale
Price
32.18
Quantity 30,464
Value US$980,264
3.5
Mazzariello Gina Chief Legal Officer Officer
Transaction date
Planned sale
Price
17.61
Quantity 15,000 -7.7%
Value US$264,122
3.5
Mazzariello Gina Chief Legal Officer Officer
Transaction date
Planned sale
Price
18.32
Quantity 15,000 -7.2%
Value US$274,746
3.5
GINA MAZZARIELLO Officer Officer
Transaction date
Proposed sale
Price
17.88
Quantity 30,000
Value US$536,400
4.0
Firestone Karen Non-Executive Director
Transaction date
Purchase
Price
13.51
Quantity 3,800 +6.0%
Value US$51,338
2.9
Cohen Joshua B Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
14.48
Quantity 29,282 -0.9%
Value US$424,120
2.9
Klee Justin B. Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
14.47
Quantity 29,282 -0.9%
Value US$423,760
3.7
Bedrosian Camille L Chief Medical Officer Officer
Transaction date
Sale
Price
14.58
Quantity 6,461 -3.7%
Value US$94,205
3.5
Mazzariello Gina Chief Legal Officer Officer
Transaction date
Sale
Price
14.52
Quantity 6,844 -4.8%
Value US$99,378
4.0
FRATES JAMES M Chief Financial Officer Officer
Transaction date
Sale
Price
14.52
Quantity 7,909 -4.6%
Value US$114,851
3.7
Bedrosian Camille L Officer Officer
Transaction date
Proposed sale
Price
14.58
Quantity 6,461
Value US$94,205
4.0
Frates James M Officer Officer
Transaction date
Proposed sale
Price
14.52
Quantity 7,909
Value US$114,852
3.5
Mazzariello Gina Officer Officer
Transaction date
Proposed sale
Price
14.52
Quantity 6,844
Value US$99,379
2.9
Cohen Joshua B Officer; Director Executive Director
Transaction date
Proposed sale
Price
14.48
Quantity 29,282
Value US$424,120
2.9
Klee Justin B. Officer; Director Executive Director
Transaction date
Proposed sale
Price
14.47
Quantity 29,282
Value US$423,760
3.5
Mazzariello Gina Chief Legal Officer Officer
Transaction date
Sale
Price
14.14
Quantity 3,419 -2.4%
Value US$48,352
3.5
Mazzariello Gina Officer Officer
Transaction date
Proposed sale
Price
14.14
Quantity 3,419
Value US$48,352
2.9
Cohen Joshua B Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
14.68
Quantity 15,500 -0.5%
Value US$227,593
3.5
Mazzariello Gina Chief Legal Officer Officer
Transaction date
Sale
Price
14.65
Quantity 3,448 -2.3%
Value US$50,516
2.9
Klee Justin B. Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
14.69
Quantity 15,500 -0.5%
Value US$227,618
4.0
FRATES JAMES M Chief Financial Officer Officer
Transaction date
Sale
Price
14.65
Quantity 3,557 -2.0%
Value US$52,097
2.9
Cohen Joshua B Officer; Director Executive Director
Transaction date
Proposed sale
Price
14.68
Quantity 15,500
Value US$227,593
2.9
Klee Justin B. Officer; Director Executive Director
Transaction date
Proposed sale
Price
14.68
Quantity 15,500
Value US$227,617
3.5
Mazzariello Gina Officer Officer
Transaction date
Proposed sale
Price
14.65
Quantity 3,448
Value US$50,515
4.0
Frates James M Officer Officer
Transaction date
Proposed sale
Price
14.65
Quantity 3,557
Value US$52,097
2.9
Klee Justin B. Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
13.89
Quantity 1,995 -0.1%
Value US$27,701
2.9
Cohen Joshua B Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
13.83
Quantity 1,974 -0.1%
Value US$27,299
2.9
JUSTIN KLEE Director; Officer Executive Director
Transaction date
Proposed sale
Price
13.52
Quantity 1,995
Value US$26,972
2.9
JOSHUA COHEN Director; Officer Executive Director
Transaction date
Proposed sale
Price
13.52
Quantity 1,974
Value US$26,688
2.9
Klee Justin B. Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
13.58
Quantity 136,193 -3.9%
Value US$1,849,869
2.9
Cohen Joshua B Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
13.59
Quantity 136,193 -3.9%
Value US$1,850,795
2.9
JOSHUA COHEN Director; Officer Executive Director
Transaction date
Proposed sale
Price
14.07
Quantity 136,193
Value US$1,916,236
2.9
JUSTIN KLEE Director; Officer Executive Director
Transaction date
Proposed sale
Price
14.07
Quantity 136,193
Value US$1,916,236
2.9
Klee Justin B. Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
11.09
Quantity 7,715 -0.2%
Value US$85,589
2.9
Cohen Joshua B Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
11.09
Quantity 7,715 -0.2%
Value US$85,596
4.0
FRATES JAMES M Chief Financial Officer Officer
Transaction date
Sale
Price
11.11
Quantity 3,326 -1.8%
Value US$36,954
4.0
Frates James M Officer Officer
Transaction date
Proposed sale
Price
11.11
Quantity 3,326
Value US$36,954
2.9
Klee Justin B. Officer; Director Executive Director
Transaction date
Proposed sale
Price
11.09
Quantity 7,715
Value US$85,590
2.9
Cohen Joshua B Officer; Director Executive Director
Transaction date
Proposed sale
Price
11.09
Quantity 7,715
Value US$85,597
4.0
Firestone Karen Non-Executive Director
Transaction date
Purchase
Price
12.45
Quantity 8,100 +14.7%
Value US$100,845
3.7
Bedrosian Camille L Chief Medical Officer Officer
Transaction date
Sale
Price
14.35
Quantity 6,580 -3.6%
Value US$94,418
3.7
Bedrosian Camille L Officer Officer
Transaction date
Proposed sale
Price
14.35
Quantity 6,580
Value US$94,419
3.7
Bedrosian Camille L Chief Medical Officer Officer
Transaction date
Sale
Price
14.58
Quantity 12,039 -6.2%
Value US$175,518
3.5
Mazzariello Gina Chief Legal Officer Officer
Transaction date
Sale
Price
14.58
Quantity 8,828 -5.6%
Value US$128,669
2.9
Cohen Joshua B Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
15.00
Quantity 200 -0.0%
Value US$3,000
2.9
Cohen Joshua B Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
14.34
Quantity 29,733 -0.9%
Value US$426,469
4.0
FRATES JAMES M Chief Financial Officer Officer
Transaction date
Sale
Price
14.65
Quantity 10,558 -3.6%
Value US$154,650
2.9
Klee Justin B. Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
15.01
Quantity 200 -0.0%
Value US$3,002
2.9
Klee Justin B. Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
14.37
Quantity 29,775 -0.9%
Value US$427,950
3.5
Mazzariello Gina Chief Legal Officer Officer
Transaction date
Planned sale
Price
8.34
Quantity 15,000 -8.7%
Value US$125,046
3.5
Mazzariello Gina Chief Legal Officer Officer
Transaction date
Planned sale
Price
8.07
Quantity 15,000 -8.0%
Value US$121,102
3.5
GINA MAZZARIELLO Officer Officer
Transaction date
Proposed sale
Price
7.82
Quantity 30,000
Value US$234,600
4.0
FRATES JAMES M Chief Financial Officer Officer
Transaction date
Sale
Price
3.47
Quantity 10,896 -3.6%
Value US$37,806
3.5
Mazzariello Gina Chief Legal Officer Officer
Transaction date
Sale
Price
3.48
Quantity 9,192 -4.7%
Value US$31,954
3.7
Bedrosian Camille L Chief Medical Officer Officer
Transaction date
Sale
Price
3.47
Quantity 12,425 -6.0%
Value US$43,082
2.9
Klee Justin B. Co-Chief Executive Officer Executive Director
Transaction date
Sale
Price
3.46
Quantity 21,490 -0.6%
Value US$74,454
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-09 2026-11-09 PrS Proposed sale
2.9
JUSTIN KLEE

Director; Officer

Executive Director
44,898
478.95
US$3,053,805 		44,898 478.95 US$3,053,805
2026-11-09 2026-11-09 PrS Proposed sale
4.0
JAMES M FRATES

Officer

Officer
45,328
69.18
US$1,056,817 		45,328 69.18 US$1,056,817
2026-11-09 2026-11-09 PrS Proposed sale
2.9
JOSHUA BARRY COHEN

Director; Officer

Executive Director
33,673
128.50
US$4,467,534 		33,673 128.50 US$4,467,534
2026-10-07 2026-10-05 PlS Planned sale
3.3
MILNE GEORGE M JR
Non-Executive Director
30,000 -3.7%
27.70
US$830,904 		30,000 -3.7% 27.70 US$830,904
2026-10-05 2026-10-05 PrS Proposed sale
3.3
GEORGE MILNE

Director

Non-Executive Director
100,000
27.79
US$2,779,000 		100,000 27.79 US$2,779,000
2026-09-14 2026-09-10 S Sale
3.5
Mazzariello Gina

Chief Legal Officer

Officer
11 -0.0%
33.34
US$367 		11 -0.0% 33.34 US$367
2026-09-14 2026-09-10 S Sale
3.5
Mazzariello Gina

Chief Legal Officer

Officer
9,525 -4.8%
32.46
US$309,140 		9,525 -4.8% 32.46 US$309,140
2026-09-14 2026-09-10 S Sale
2.9
Cohen Joshua B

Co-Chief Executive Officer

Executive Director
919 -0.0%
33.15
US$30,464 		919 -0.0% 33.15 US$30,464
2026-09-14 2026-09-10 S Sale
2.9
Cohen Joshua B

Co-Chief Executive Officer

Executive Director
29,545 -0.8%
32.16
US$950,040 		29,545 -0.8% 32.16 US$950,040
2026-09-14 2026-09-10 S Sale
2.9
Klee Justin B.

Co-Chief Executive Officer

Executive Director
1,439 -0.0%
33.16
US$47,710 		1,439 -0.0% 33.16 US$47,710
2026-09-14 2026-09-10 S Sale
2.9
Klee Justin B.

Co-Chief Executive Officer

Executive Director
29,025 -0.8%
32.13
US$932,553 		29,025 -0.8% 32.13 US$932,553
2026-09-14 2026-09-10 S Sale
3.7
Bedrosian Camille L

Chief Medical Officer

Officer
2,081 -0.7%
33.09
US$68,864 		2,081 -0.7% 33.09 US$68,864
2026-09-14 2026-09-10 S Sale
3.7
Bedrosian Camille L

Chief Medical Officer

Officer
7,947 -2.8%
32.21
US$256,004 		7,947 -2.8% 32.21 US$256,004
2026-09-14 2026-09-10 S Sale
4.0
FRATES JAMES M

Chief Financial Officer

Officer
1,042 -0.4%
33.23
US$34,626 		1,042 -0.4% 33.23 US$34,626
2026-09-14 2026-09-10 S Sale
4.0
FRATES JAMES M

Chief Financial Officer

Officer
9,768 -4.0%
32.27
US$315,195 		9,768 -4.0% 32.27 US$315,195
2026-09-11 2026-09-10 PrS Proposed sale
3.5
Mazzariello Gina

Officer

Officer
9,536
32.46
US$309,506 		9,536 32.46 US$309,506
2026-09-11 2026-09-10 PrS Proposed sale
4.0
Frates James M

Officer

Officer
10,810
32.36
US$349,821 		10,810 32.36 US$349,821
2026-09-11 2026-09-10 PrS Proposed sale
2.9
Cohen Joshua B

Officer; Director

Executive Director
30,464
32.19
US$980,504 		30,464 32.19 US$980,504
2026-09-11 2026-09-10 PrS Proposed sale
3.7
Bedrosian Camille L

Officer

Officer
10,028
32.40
US$324,868 		10,028 32.40 US$324,868
2026-09-11 2026-09-10 PrS Proposed sale
2.9
Klee Justin B.

Officer; Director

Executive Director
30,464
32.18
US$980,264 		30,464 32.18 US$980,264
2026-07-13 2026-07-10 PlS Planned sale
3.5
Mazzariello Gina

Chief Legal Officer

Officer
15,000 -7.7%
17.61
US$264,122 		15,000 -7.7% 17.61 US$264,122
2026-07-13 2026-07-09 PlS Planned sale
3.5
Mazzariello Gina

Chief Legal Officer

Officer
15,000 -7.2%
18.32
US$274,746 		15,000 -7.2% 18.32 US$274,746
2026-07-09 2026-07-09 PrS Proposed sale
3.5
GINA MAZZARIELLO

Officer

Officer
30,000
17.88
US$536,400 		30,000 17.88 US$536,400
2026-05-26 2026-05-21 B Purchase
4.0
Firestone Karen
Non-Executive Director
3,800 +6.0%
13.51
US$51,338 		3,800 +6.0% 13.51 US$51,338
2026-03-04 2026-03-02 S Sale
2.9
Cohen Joshua B

Co-Chief Executive Officer

Executive Director
29,282 -0.9%
14.48
US$424,120 		29,282 -0.9% 14.48 US$424,120
2026-03-04 2026-03-02 S Sale
2.9
Klee Justin B.

Co-Chief Executive Officer

Executive Director
29,282 -0.9%
14.47
US$423,760 		29,282 -0.9% 14.47 US$423,760
2026-03-04 2026-03-02 S Sale
3.7
Bedrosian Camille L

Chief Medical Officer

Officer
6,461 -3.7%
14.58
US$94,205 		6,461 -3.7% 14.58 US$94,205
2026-03-04 2026-03-02 S Sale
3.5
Mazzariello Gina

Chief Legal Officer

Officer
6,844 -4.8%
14.52
US$99,378 		6,844 -4.8% 14.52 US$99,378
2026-03-04 2026-03-02 S Sale
4.0
FRATES JAMES M

Chief Financial Officer

Officer
7,909 -4.6%
14.52
US$114,851 		7,909 -4.6% 14.52 US$114,851
2026-03-02 2026-03-02 PrS Proposed sale
3.7
Bedrosian Camille L

Officer

Officer
6,461
14.58
US$94,205 		6,461 14.58 US$94,205
2026-03-02 2026-03-02 PrS Proposed sale
4.0
Frates James M

Officer

Officer
7,909
14.52
US$114,852 		7,909 14.52 US$114,852
2026-03-02 2026-03-02 PrS Proposed sale
3.5
Mazzariello Gina

Officer

Officer
6,844
14.52
US$99,379 		6,844 14.52 US$99,379
2026-03-02 2026-03-02 PrS Proposed sale
2.9
Cohen Joshua B

Officer; Director

Executive Director
29,282
14.48
US$424,120 		29,282 14.48 US$424,120
2026-03-02 2026-03-02 PrS Proposed sale
2.9
Klee Justin B.

Officer; Director

Executive Director
29,282
14.47
US$423,760 		29,282 14.47 US$423,760
2026-02-25 2026-02-23 S Sale
3.5
Mazzariello Gina

Chief Legal Officer

Officer
3,419 -2.4%
14.14
US$48,352 		3,419 -2.4% 14.14 US$48,352
2026-02-23 2026-02-23 PrS Proposed sale
3.5
Mazzariello Gina

Officer

Officer
3,419
14.14
US$48,352 		3,419 14.14 US$48,352
2026-02-04 2026-02-02 S Sale
2.9
Cohen Joshua B

Co-Chief Executive Officer

Executive Director
15,500 -0.5%
14.68
US$227,593 		15,500 -0.5% 14.68 US$227,593
2026-02-04 2026-02-02 S Sale
3.5
Mazzariello Gina

Chief Legal Officer

Officer
3,448 -2.3%
14.65
US$50,516 		3,448 -2.3% 14.65 US$50,516
2026-02-04 2026-02-02 S Sale
2.9
Klee Justin B.

Co-Chief Executive Officer

Executive Director
15,500 -0.5%
14.69
US$227,618 		15,500 -0.5% 14.69 US$227,618
2026-02-04 2026-02-02 S Sale
4.0
FRATES JAMES M

Chief Financial Officer

Officer
3,557 -2.0%
14.65
US$52,097 		3,557 -2.0% 14.65 US$52,097
2026-02-02 2026-02-02 PrS Proposed sale
2.9
Cohen Joshua B

Officer; Director

Executive Director
15,500
14.68
US$227,593 		15,500 14.68 US$227,593
2026-02-02 2026-02-02 PrS Proposed sale
2.9
Klee Justin B.

Officer; Director

Executive Director
15,500
14.68
US$227,617 		15,500 14.68 US$227,617
2026-02-02 2026-02-02 PrS Proposed sale
3.5
Mazzariello Gina

Officer

Officer
3,448
14.65
US$50,515 		3,448 14.65 US$50,515
2026-02-02 2026-02-02 PrS Proposed sale
4.0
Frates James M

Officer

Officer
3,557
14.65
US$52,097 		3,557 14.65 US$52,097
2026-01-20 2026-01-16 S Sale
2.9
Klee Justin B.

Co-Chief Executive Officer

Executive Director
1,995 -0.1%
13.89
US$27,701 		1,995 -0.1% 13.89 US$27,701
2026-01-20 2026-01-16 S Sale
2.9
Cohen Joshua B

Co-Chief Executive Officer

Executive Director
1,974 -0.1%
13.83
US$27,299 		1,974 -0.1% 13.83 US$27,299
2026-01-16 2026-01-16 PrS Proposed sale
2.9
JUSTIN KLEE

Director; Officer

Executive Director
1,995
13.52
US$26,972 		1,995 13.52 US$26,972
2026-01-16 2026-01-16 PrS Proposed sale
2.9
JOSHUA COHEN

Director; Officer

Executive Director
1,974
13.52
US$26,688 		1,974 13.52 US$26,688
2026-01-20 2026-01-15 S Sale
2.9
Klee Justin B.

Co-Chief Executive Officer

Executive Director
136,193 -3.9%
13.58
US$1,849,869 		136,193 -3.9% 13.58 US$1,849,869
2026-01-20 2026-01-15 S Sale
2.9
Cohen Joshua B

Co-Chief Executive Officer

Executive Director
136,193 -3.9%
13.59
US$1,850,795 		136,193 -3.9% 13.59 US$1,850,795
2026-01-15 2026-01-15 PrS Proposed sale
2.9
JOSHUA COHEN

Director; Officer

Executive Director
136,193
14.07
US$1,916,236 		136,193 14.07 US$1,916,236
2026-01-15 2026-01-15 PrS Proposed sale
2.9
JUSTIN KLEE

Director; Officer

Executive Director
136,193
14.07
US$1,916,236 		136,193 14.07 US$1,916,236
2026-01-08 2026-01-06 S Sale
2.9
Klee Justin B.

Co-Chief Executive Officer

Executive Director
7,715 -0.2%
11.09
US$85,589 		7,715 -0.2% 11.09 US$85,589
2026-01-08 2026-01-06 S Sale
2.9
Cohen Joshua B

Co-Chief Executive Officer

Executive Director
7,715 -0.2%
11.09
US$85,596 		7,715 -0.2% 11.09 US$85,596
2026-01-08 2026-01-06 S Sale
4.0
FRATES JAMES M

Chief Financial Officer

Officer
3,326 -1.8%
11.11
US$36,954 		3,326 -1.8% 11.11 US$36,954
2026-01-06 2026-01-06 PrS Proposed sale
4.0
Frates James M

Officer

Officer
3,326
11.11
US$36,954 		3,326 11.11 US$36,954
2026-01-06 2026-01-06 PrS Proposed sale
2.9
Klee Justin B.

Officer; Director

Executive Director
7,715
11.09
US$85,590 		7,715 11.09 US$85,590
2026-01-06 2026-01-06 PrS Proposed sale
2.9
Cohen Joshua B

Officer; Director

Executive Director
7,715
11.09
US$85,597 		7,715 11.09 US$85,597
2025-12-23 2025-12-23 B Purchase
4.0
Firestone Karen
Non-Executive Director
8,100 +14.7%
12.45
US$100,845 		8,100 +14.7% 12.45 US$100,845
2025-12-03 2025-12-01 S Sale
3.7
Bedrosian Camille L

Chief Medical Officer

Officer
6,580 -3.6%
14.35
US$94,418 		6,580 -3.6% 14.35 US$94,418
2025-12-01 2025-12-01 PrS Proposed sale
3.7
Bedrosian Camille L

Officer

Officer
6,580
14.35
US$94,419 		6,580 14.35 US$94,419
2025-10-02 2025-09-30 S Sale
3.7
Bedrosian Camille L

Chief Medical Officer

Officer
12,039 -6.2%
14.58
US$175,518 		12,039 -6.2% 14.58 US$175,518
2025-10-02 2025-09-30 S Sale
3.5
Mazzariello Gina

Chief Legal Officer

Officer
8,828 -5.6%
14.58
US$128,669 		8,828 -5.6% 14.58 US$128,669
2025-10-02 2025-09-30 S Sale
2.9
Cohen Joshua B

Co-Chief Executive Officer

Executive Director
200 -0.0%
15.00
US$3,000 		200 -0.0% 15.00 US$3,000
2025-10-02 2025-09-30 S Sale
2.9
Cohen Joshua B

Co-Chief Executive Officer

Executive Director
29,733 -0.9%
14.34
US$426,469 		29,733 -0.9% 14.34 US$426,469
2025-10-02 2025-09-30 S Sale
4.0
FRATES JAMES M

Chief Financial Officer

Officer
10,558 -3.6%
14.65
US$154,650 		10,558 -3.6% 14.65 US$154,650
2025-10-02 2025-09-30 S Sale
2.9
Klee Justin B.

Co-Chief Executive Officer

Executive Director
200 -0.0%
15.01
US$3,002 		200 -0.0% 15.01 US$3,002
2025-10-02 2025-09-30 S Sale
2.9
Klee Justin B.

Co-Chief Executive Officer

Executive Director
29,775 -0.9%
14.37
US$427,950 		29,775 -0.9% 14.37 US$427,950
2025-08-14 2025-08-13 PlS Planned sale
3.5
Mazzariello Gina

Chief Legal Officer

Officer
15,000 -8.7%
8.34
US$125,046 		15,000 -8.7% 8.34 US$125,046
2025-08-14 2025-08-12 PlS Planned sale
3.5
Mazzariello Gina

Chief Legal Officer

Officer
15,000 -8.0%
8.07
US$121,102 		15,000 -8.0% 8.07 US$121,102
2025-08-12 2025-08-12 PrS Proposed sale
3.5
GINA MAZZARIELLO

Officer

Officer
30,000
7.82
US$234,600 		30,000 7.82 US$234,600
2025-04-02 2025-03-31 S Sale
4.0
FRATES JAMES M

Chief Financial Officer

Officer
10,896 -3.6%
3.47
US$37,806 		10,896 -3.6% 3.47 US$37,806
2025-04-02 2025-03-31 S Sale
3.5
Mazzariello Gina

Chief Legal Officer

Officer
9,192 -4.7%
3.48
US$31,954 		9,192 -4.7% 3.48 US$31,954
2025-04-02 2025-03-31 S Sale
3.7
Bedrosian Camille L

Chief Medical Officer

Officer
12,425 -6.0%
3.47
US$43,082 		12,425 -6.0% 3.47 US$43,082
2025-04-02 2025-03-31 S Sale
2.9
Klee Justin B.

Co-Chief Executive Officer

Executive Director
21,490 -0.6%
3.46
US$74,454 		21,490 -0.6% 3.46 US$74,454

See older Amylyx Pharmaceuticals, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Amylyx Pharmaceuticals, Inc. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Amylyx Pharmaceuticals, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America